Dashboard
Manage Tickers

LFVN Lifevantage Corp

Nasdaq lifevantage.com


$ 6.56 $ -0.68 (-9.37 %)    

Tuesday, 11-Nov-2025 15:59:58 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 622.49 $ 0.90 (0.15 %)
DIA $ 479.63 $ 5.34 (1.13 %)
SPY $ 683.37 $ 2.90 (0.43 %)
TLT $ 89.91 $ 0.01 (0.01 %)
GLD $ 380.58 $ -0.09 (-0.02 %)
$ 6.58
$ 7.25
$ 6.51 x 21
$ 7.65 x 2
$ 6.52 - $ 7.28
$ 6.52 - $ 27.12
382,885
na
83.57M
$ 0.38
$ 8.25
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 09-04-2025 06-30-2025 10-K
3 05-06-2025 03-31-2025 10-Q
4 02-05-2025 12-31-2024 10-Q
5 10-29-2024 09-30-2024 10-Q
6 08-28-2024 06-30-2024 10-K
7 05-02-2024 03-31-2024 10-Q
8 01-30-2024 12-31-2023 10-Q
9 11-09-2023 09-30-2023 10-Q
10 08-28-2023 06-30-2023 10-K
11 05-04-2023 03-31-2023 10-Q
12 02-02-2023 12-31-2022 10-Q
13 11-02-2022 09-30-2022 10-Q
14 08-23-2022 06-30-2022 10-K
15 05-03-2022 03-31-2022 10-Q
16 02-01-2022 12-31-2021 10-Q
17 11-04-2021 09-30-2021 10-Q
18 08-19-2021 06-30-2021 10-K
19 04-29-2021 03-31-2021 10-Q
20 02-02-2021 12-31-2020 10-Q
21 11-03-2020 09-30-2020 10-Q
22 08-18-2020 06-30-2020 10-K
23 05-05-2020 03-31-2020 10-Q
24 01-28-2020 12-31-2019 10-Q
25 10-30-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-K
27 05-01-2019 03-31-2019 10-Q
28 02-04-2019 12-31-2018 10-Q
29 11-01-2018 09-30-2018 10-Q
30 08-15-2018 06-30-2018 10-K
31 05-09-2018 03-31-2018 10-Q
32 02-07-2018 12-31-2017 10-Q
33 11-08-2017 09-30-2017 10-Q
34 09-07-2017 06-30-2017 10-K
35 05-10-2017 03-31-2017 10-Q
36 02-08-2017 12-31-2016 10-Q
37 12-12-2016 06-30-2016 10-K
38 12-12-2016 09-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 02-09-2016 12-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

lifevantage-affirms-fy2026-adj-eps-guidance-of-100-115-vs-097-est-affirms-fy2026-sales-guidance-of-225000m-240000m-vs-239567m-est
Lifevantage Affirms FY2026 Adj EPS Guidanc...
11/04/2025 21:06:43

Lifevantage (NASDAQ:LFVN) affirms FY2026 Adj EPS guidance from $1.00-$1.15 to $1.00-$1.15 vs $0.97 analyst estimate. Affirms FY...

lifevantage-q1-adj-eps-018-inline-sales-47561m-miss-54750m-estimate
Lifevantage Q1 Adj. EPS $0.18, Inline, Sal...
11/04/2025 21:05:53

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.18 per share which met the analyst consensus estimate. This is a 20...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

correction-on-september-4-2025-lifevantage-reported-that-it-sees-fy2026-adj-eps-100-115-vs-100-est-sees-sales-225000m-240000m-vs-252400m-est
CORRECTION: On September 4, 2025 Lifevanta...
09/06/2025 16:03:59

Lifevantage (NASDAQ:LFVN) is looking for FY2026 Adj EPS of $1.00-$1.15 vs $1.00 analyst estimate. sees sales of $225.000 millio...

american-outdoor-brands-posts-downbeat-results-joins-lululemon-quanex-building-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
American Outdoor Brands Posts Downbeat Res...
09/05/2025 12:48:05

why-docusign-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Docusign Shares Are Trading Higher By ...
09/05/2025 09:20:59

lifevantage-q4-adj-eps-017-beats-015-estimate-sales-55114m-miss-56900m-estimate
Lifevantage Q4 Adj. EPS $0.17 Beats $0.15 ...
09/04/2025 20:05:51

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.15 by ...

Core News & Articles
Earnings Scheduled For September 4, 2025
09/04/2025 08:32:12

lifevantage-acquires-lovebiome-terms-not-disclosed
LifeVantage Acquires LoveBiome; Terms Not ...
09/03/2025 21:14:41

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company ...

whats-next-lifevantages-earnings-preview
What's Next: Lifevantage's Earnings Preview
09/03/2025 16:01:56

lifevantage-expands-human-clinical-study-for-mindbody-glp-1-system
LifeVantage Expands Human Clinical Study F...
07/22/2025 12:09:47

lifevantage-raises-fy2025-adj-eps-guidance-from-070-080-to-072-088-vs-078-est-lowers-fy2025-sales-guidance-from-23500m-24500m-to-22800m-23500m-vs-23974m-est
Lifevantage Raises FY2025 Adj EPS Guidance...
05/06/2025 20:15:01

Lifevantage (NASDAQ:LFVN) raises FY2025 Adj EPS guidance from $0.70-$0.80 to $0.72-$0.88 vs $0.78 analyst estimate. Lowers FY20...

lifevantage-q3-eps-026-beats-014-estimate-sales-5840m-miss-6096m-estimate
Lifevantage Q3 EPS $0.26 Beats $0.14 Estim...
05/06/2025 20:11:56

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.14 by ...

lifevantage-board-raises-quarterly-cash-dividend-by-125-to-from-004-to-0045-per-share
LifeVantage Board Raises Quarterly Cash Di...
05/06/2025 20:10:38

LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health ...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

why-reshape-lifesciences-shares-are-trading-higher-by-over-82-here-are-20-stocks-moving-premarket
Why ReShape Lifesciences Shares Are Tradin...
04/10/2025 09:26:21

Core News & Articles
FDA Says Novo Nordisk's Ozempic Injection ...
02/21/2025 14:22:44

earnings-breakdown-lifevantage-q2
Earnings Breakdown: Lifevantage Q2
02/05/2025 21:55:56

lifevantage-q2-earnings-insights
Lifevantage: Q2 Earnings Insights
02/05/2025 21:51:59

lifevantage-q2-earnings-assessment
Lifevantage Q2 Earnings Assessment
02/05/2025 21:45:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION